UniProt/SwissProt ID: | ANXA2_HUMAN |
Description: | annexin A2 [Source:HGNC Symbol;Acc:537] |
Location: | chr15 q22.2 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
T21 | SFKMStVHEIL | HPRD | |
S314 | RKYGKsLYYYI | Annexin | PhosphoSitePlus |
T123 | MKGLGtDEDSL | HPRD; SysPTM | |
Y24 | TPPSAyGSVKA | Src | RegPhos; SysPTM |
S85 | KKELAsALKSA | Annexin | PhosphoSitePlus |
S92 | LKSALsGHLET | Annexin | PhosphoSitePlus |
Y24 | TPPSAyGSVKA | SRC | phosphoELM; RegPhos; SysPTM |
Y147 | EINRVyKEMYK | Annexin; YodA | PhosphoSitePlus |
T19 | EGDHStPPSAY | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
T3 | HEIL | HPRD; phosphoELM; SysPTM | |
Y206 | GSVIDyELIDQ | HPRD | |
Y109 | KTPAQyDASEL | Annexin | PhosphoSitePlus |
Y235 | DRYKSySPYDM | YodA; Annexin | PhosphoSitePlus |
S234 | FDRYKsYSPYD | YodA; Annexin | PhosphoSitePlus |
T171 | KEMYKtDLEKD | HPRD | |
T3 | MSTVHeIL | RegPhos; SysPTM | |
Y334 | YGKSLyYYIQQ | HPRD | |
Y199 | DARDLyDAGVK | YodA; Annexin | PhosphoSitePlus |
Y199 | DARDLyDAGVK | HPRD; phosphoELM | |
Y42 | TPPSAyGSVKA | HPRD | |
Y316 | YGKSLyYYIQQ | Annexin | PhosphoSitePlus |
S44 | PSAYGsVKAYT | PRKCA | HPRD |
Y316 | YGKSLyYYIQQ | HPRD; phosphoELM | |
Y256 | KSYSPyDMLES | HPRD | |
S22 | HSTPPsAYGSV | PhosphoSitePlus; HPRD | |
S127 | GTDEDsLIEII | Annexin; YodA | PhosphoSitePlus |
Y188 | GSVIDyELIDQ | YodA | PhosphoSitePlus |
Y75 | DIAFAyQRRTK | HPRD | |
S184 | RAEDGsVIDYE | YodA | PhosphoSitePlus |
Y336 | KSLYYyIQQDT | HPRD | |
Y333 | QKALLyLCGGD | Annexin | PhosphoSitePlus |
Y335 | GKSLYyYIQQD | HPRD | |
Y48 | GSVKAyTNFDA | HPRD | |
S12 | ILCKLsLEGDH | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
Y275 | FADRLyDSMKG | Annexin | PhosphoSitePlus |
S2 | VHEI | PRKCB | HPRD |
Y317 | GKSLYyYIQQD | HPRD; phosphoELM | |
T153 | KEMYKtDLEKD | HPRD | |
S202 | RAEDGsVIDYE | HPRD | |
Y238 | KSYSPyDMLES | YodA; Annexin | PhosphoSitePlus |
S40 | HSTPPsAYGSV | HPRD | |
Y24 | TPPSAyGSVKA | PhosphoSitePlus; HPRD; phosphoELM; RegPhos; SysPTM | |
S134 | IEIICsRTNQE | Annexin; YodA | PhosphoSitePlus |
S20 | ASFKMsTVHEI | PRKCB | HPRD |
S145 | GTDEDsLIEII | HPRD | |
T136 | IICSRtNQELQ | Annexin; YodA | PhosphoSitePlus |
S2 | VHEI | HPRD | |
Y317 | GKSLYyYIQQD | Annexin | PhosphoSitePlus |
Y147 | EINRVyKEMYK | HPRD | |
S30 | ILCKLsLEGDH | HPRD | |
Y165 | EINRVyKEMYK | HPRD | |
Y30 | GSVKAyTNFDA | PhosphoSitePlus; HPRD; phosphoELM; RegPhos; SysPTM | |
S26 | PSAYGsVKAYT | PRKCA | HPRD |
S127 | GTDEDsLIEII | HPRD | |
S18 | LEGDHsTPPSA | PhosphoSitePlus; HPRD; phosphoELM; RegPhos; SysPTM | |
S243 | YDMLEsIRKEV | YodA; Annexin | PhosphoSitePlus |
S26 | PSAYGsVKAYT | PKCa | RegPhos |
S26 | PSAYGsVKAYT | PKCa(PKC alpha | RegPhos |
T3 | ___MStVHEIL | PhosphoSitePlus; SysPTM | |
Y75 | DIAFAyQRRTK | Annexin | PhosphoSitePlus |
S26 | PSAYGsVKAYT | PhosphoSitePlus; phosphoELM | |
T31 | SVKAYtNFDAE | PhosphoSitePlus | |
S36 | LEGDHsTPPSA | HPRD | |
S2 | MSTVHeI | PKCb | RegPhos |
T123 | MKGLGtDEDSL | Annexin; YodA | PhosphoSitePlus; SysPTM |
Y217 | DARDLyDAGVK | HPRD | |
Y188 | GSVIDyELIDQ | HPRD; phosphoELM | |
T141 | MKGLGtDEDSL | HPRD | |
S184 | RAEDGsVIDYE | HPRD | |
Y232 | KVFDRyKSYSP | YodA; Annexin | PhosphoSitePlus |
Y318 | KSLYYyIQQDT | HPRD; phosphoELM | |
Y93 | DIAFAyQRRTK | HPRD | |
Y238 | KSYSPyDMLES | HPRD; phosphoELM | |
Y318 | KSLYYyIQQDT | Annexin | PhosphoSitePlus |
S26 | PSAYGsVKAYT | PKC_alpha | phosphoELM |
T37 | EGDHStPPSAY | HPRD | |
S26 | PSAYGsVKAYT | PKC_group | phosphoELM; RegPhos |
Dephosphorylation site |
ANXA2_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000346032 | T141P | COSMIC | Ovarian Cancer | 21720365 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000411352 | Leukemia | Normal vs. Cancer | cell line | Up | 2.4 | 17022645 |
ENSP00000411352 | Leukemia | Normal vs. Cancer | cell line | Up | 2.2 | 17022645 |
ENSP00000411352 | breast ductal carcinoma | Normal vs. Cancer | tissue | Up | 18482919 | |
ENSP00000411352 | Breast Cancer | Normal vs. Cancer | cell line | Up | 4 | 14997480 |
ENSP00000411352 | Breast Cancer | Normal vs. Cancer | cell line | Down | 0.11 | 16596714 |
ENSP00000411352 | Breast Cancer | Normal vs. Cancer | cell line | Down | 0.26 | 16596714 |
ENSP00000411352 | Breast Cancer | Normal vs. Cancer | cell line | Down | 0.26 | 16596714 |
ENSP00000411352 | Melanoma | Treatment (none vs. metastasis suppressor 1 (BRMS1) overEXPressed) | cell line | Down | 0.67 | 17854218 |
ENSP00000411352 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 2.4 | 11866469 |
ENSP00000411352 | Hepatocellular Carcinoma | Normal vs. Cancer | cell line | Up | 3.4 | 19120023 |
ENSP00000411352 | Hepatocellular Carcinoma | Cancer vs. Cancer (HCC vs. HuCCA) | cell line | Up | 20069059 | |
ENSP00000411352 | Lung Cancer | Normal vs. Cancer | tissue | Down | 16342241 | |
ENSP00000411352 | Lung Cancer | Cancer vs. Cancer | cell line | Up | 17284061 | |
ENSP00000411352 | Lung Cancer | Treatment(none vs 20 mg/mL GTE treatment) | cell line | Up | 2.8 | 19137550 |
ENSP00000411352 | Lung Cancer | Treatment(none vs 40 mg/mL GTE treatment) | cell line | Up | 2.6 | 19137550 |
ENSP00000411352 | Gastric Cancer | Normal vs. Cancer | tissue | Down | 0.43 | 19330469 |
ENSP00000411352 | Breast Cancer | Metastasis | cell line | Up | 2 | 19321434 |
ENSP00000411352 | Breast Cancer | Normal vs. Cancer | cell line | Down | 0.12 | 20052998 |
ENSP00000411352 | Breast Cancer | Normal vs. Cancer | cell line | Down | 0.18 | 20052998 |
ENSP00000411352 | Breast Cancer | Normal vs. Cancer | cell line | Down | 0.28 | 20052998 |
ENSP00000411352 | Breast Cancer | Normal vs. Cancer | cell line | Down | 0.42 | 20052998 |
ENSP00000411352 | Breast Cancer | Metastasis | cell line | Up | 2.4 | 20052998 |
ENSP00000411352 | Breast Cancer | Metastasis | cell line | Up | 2.5 | 20052998 |
ENSP00000411352 | Breast Cancer | Normal vs. Cancer | tissue | Up | 1.7 | 20087651 |
ENSP00000411352 | Breast Cancer | Normal vs. Cancer | tissue | Up | 2 | 20087651 |
ENSP00000411352 | Breast Cancer | Cancer vs. Cancer (Non-TNBC vs. TNBC) | cell line | Up | 20596302 | |
ENSP00000411352 | breast ductal carcinoma | Normal vs. Cancer | tissue | Up | 18564057 | |
ENSP00000411352 | Renal Cancer | Normal vs. Cancer | tissue | Up | 2.9-10.4 | 12923786 |
ENSP00000411352 | Ovarian Cancer | Metastasis | cell line | Down | 0.4 | 17892554 |
ENSP00000411352 | Pancreatic Cancer | Normal vs. Cancer | tissue | Up | 2 | 15526344 |
ENSP00000411352 | Uterine Cancer | Normal vs. Cancer | tissue | Up | 16051329 | |
ENSP00000411352 | Uterine Cancer | Normal vs. Cancer | tissue | Up | 19771267 | |
ENSP00000411352 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 3.3 | 11866469 |
ENSP00000411352 | pancreatic ductal adenocarcinoma | Normal vs. Cancer | tissue | Up | 17492507 | |
Hyperphosphorylation site |
Site | Motif | Peptide | Cancer name | Pubmed | Source |
---|---|---|---|---|---|
Y188 | YodA | EDGSVIDyELIDQDA | cholangiocellular carcinoma | 21253578 | PhosphoSitePlus |
Y199 | YodA; Annexin | DQDARDLyDAGVKRK | cholangiocellular carcinoma | 21253578 | PhosphoSitePlus |
Y238 | YodA; Annexin | RYKSYSPyDMLESIR | cholangiocellular carcinoma | 21253578 | PhosphoSitePlus |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
KPCB_HUMAN | ANXA2_HUMAN | kinase -> substrate | HPRD |
ZAGL2_HUMAN | ANXA2_HUMAN | kinase -> substrate | RegPhos |
FGFR1_HUMAN | ANXA2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
BMX_HUMAN | ANXA2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
KPCA_HUMAN | ANXA2_HUMAN | kinase -> substrate | HPRD; Robert H Newman (2013) |
KPCZ_HUMAN | ANXA2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
SRC_HUMAN | ANXA2_HUMAN | kinase -> substrate | RegPhos |
FAK2_HUMAN | ANXA2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
SCYL2_HUMAN | ANXA2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
Function Annotation |
KEGG Pathway |
ANXA2_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0043220 | Schmidt-Lanterman incisure | IEA | cellular_component |
GO:0005509 | calcium ion binding | IEA | molecular_function |
GO:0048471 | perinuclear region of cytoplasm | IEA | cellular_component |
GO:0042470 | melanosome | IEA | cellular_component |
GO:0019897 | extrinsic to plasma membrane | IEA | cellular_component |
GO:0042730 | fibrinolysis | IEA | biological_process |
GO:0017137 | Rab GTPase binding | IEA | molecular_function |
GO:0071229 | cellular response to acid | IEA | biological_process |
GO:0007589 | body fluid secretion | IEA | biological_process |
GO:0005811 | lipid particle | IDA | cellular_component |
GO:0043234 | protein complex | IEA | cellular_component |
GO:0030199 | collagen fibril organization | IEA | biological_process |
GO:0031340 | positive regulation of vesicle fusion | IDA | biological_process |
GO:0042383 | sarcolemma | IEA | cellular_component |
GO:0005604 | basement membrane | IEA | cellular_component |
GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding | IEA | molecular_function |
GO:0004859 | phospholipase inhibitor activity | IEA | molecular_function |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0008092 | cytoskeletal protein binding | IEA | molecular_function |
GO:0001501 | skeletal system development | TAS | biological_process |
GO:0005544 | calcium-dependent phospholipid binding | IEA | molecular_function |
GO:0031012 | extracellular matrix | ISS | cellular_component |
GO:0005886 | plasma membrane | IEA | cellular_component |
GO:0030496 | midbody | IDA | cellular_component |
GO:0051099 | positive regulation of binding | IEA | biological_process |
GO:0001525 | angiogenesis | IEA | biological_process |
GO:0005737 | cytoplasm | IEA | cellular_component |
GO:0070062 | extracellular vesicular exosome | IDA | cellular_component |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0005769 | early endosome | IEA | cellular_component |
GO:0005886 | plasma membrane | TAS | cellular_component |
GO:0035749 | myelin sheath adaxonal region | IEA | cellular_component |